Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | THRB | P10828 | 1/20 | 0.34 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.34 |
| ▸ | NAAA | Q02083 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10110367 | 0.77 | SMN1; SMN2 (0.48) | SMN1; SMN2THRBALOX15 | |
| SCHEMBL16369092 | 0.77 | SMN1; SMN2 (0.48) | SMN1; SMN2THRBALOX15 | |
| SCHEMBL29884708 | 0.76 | NAAA (0.30) | NAAA | |
| SCHEMBL9254839 | 0.76 | NAAA (0.30) | NAAA | |
| SCHEMBL22591175 | 0.72 | THRB (0.36) | SMN1; SMN2THRBALOX15 | |
| SCHEMBL17867124 | 0.72 | HTT (0.31) | — | |
| SCHEMBL29134113 | 0.70 | CYP1A2 (0.43) | SMN1; SMN2CYP1A2 | |
| SCHEMBL15964115 | 0.69 | SMN1; SMN2 (0.36) | SMN1; SMN2THRBALOX15 | |
| SCHEMBL14994441 | 0.68 | SMN1; SMN2 (0.43) | SMN1; SMN2CYP1A2 | |
| SCHEMBL7178100 | 0.68 | SMN1; SMN2 (0.43) | SMN1; SMN2CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2748353-A2 | METHOD FOR THE ELECTROCHEMICAL PRODUCTION OF -HYDROXYCARBOXYLIC ESTERS AND -LACTONES | BASF SE (DE) | 2014-07-02 | — | — | EP | claimed |
| US-20140100376-A1 | PROCESS FOR THE ELECTROCHEMICAL PREPARATION OF GAMMA-HYDROXYCARBOXYLIC ESTERS AND GAMMA-LACTONES | BASF SE (DE) | 2014-04-10 | — | — | US | claimed |
| US-20130053582-A1 | PROCESS FOR THE ELECTROCHEMICAL PREPARATION OF GAMMA-HYDROXYCARBOXYLIC ESTERS AND GAMMA-LACTONES | BASF SE (DE) | 2013-02-28 | — | — | US | claimed |
| WO-2013026737-A2 | METHOD FOR THE ELECTROCHEMICAL PRODUCTION OF Γ-HYDROXYCARBOXYLIC ESTERS AND Γ-LACTONES | BASF SE (DE) | 2013-02-28 | — | — | WO | claimed |
| EP-2748353-B1 | METHOD FOR THE ELECTROCHEMICAL PRODUCTION OF GAMMA-HYDROXYCARBOXYLIC ESTERS AND GAMMA-LACTONES | BASF SE (DE) | 2017-04-26 | — | — | EP | disclosed |
| EP-2748353-B1 | METHOD FOR THE ELECTROCHEMICAL PRODUCTION OF GAMMA-HYDROXYCARBOXYLIC ESTERS AND GAMMA-LACTONES | BASF SE (DE) | 2017-04-26 | — | — | EP | disclosed |
| EP-2748353-A2 | METHOD FOR THE ELECTROCHEMICAL PRODUCTION OF -HYDROXYCARBOXYLIC ESTERS AND -LACTONES | BASF SE (DE) | 2014-07-02 | — | — | EP | disclosed |
| US-20140100376-A1 | PROCESS FOR THE ELECTROCHEMICAL PREPARATION OF GAMMA-HYDROXYCARBOXYLIC ESTERS AND GAMMA-LACTONES | BASF SE (DE) | 2014-04-10 | — | — | US | disclosed |
| US-8617376-B2 | Process for the electrochemical preparation of gamma-hydroxycarboxylic esters and gamma-lactones | BASF SE (DE) | 2013-12-31 | — | — | US | disclosed |
| US-20130053582-A1 | PROCESS FOR THE ELECTROCHEMICAL PREPARATION OF GAMMA-HYDROXYCARBOXYLIC ESTERS AND GAMMA-LACTONES | BASF SE (DE) | 2013-02-28 | — | — | US | disclosed |
| US-20130053582-A1 | PROCESS FOR THE ELECTROCHEMICAL PREPARATION OF GAMMA-HYDROXYCARBOXYLIC ESTERS AND GAMMA-LACTONES | BASF SE (DE) | 2013-02-28 | — | — | US | disclosed |
| US-20130053582-A1 | PROCESS FOR THE ELECTROCHEMICAL PREPARATION OF GAMMA-HYDROXYCARBOXYLIC ESTERS AND GAMMA-LACTONES | BASF SE (DE) | 2013-02-28 | — | — | US | disclosed |
| WO-2013026737-A2 | METHOD FOR THE ELECTROCHEMICAL PRODUCTION OF Γ-HYDROXYCARBOXYLIC ESTERS AND Γ-LACTONES | BASF SE (DE) | 2013-02-28 | — | — | WO | disclosed |
| WO-2013026737-A2 | METHOD FOR THE ELECTROCHEMICAL PRODUCTION OF Γ-HYDROXYCARBOXYLIC ESTERS AND Γ-LACTONES | BASF SE (DE) | 2013-02-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130053582-A1 | PROCESS FOR THE ELECTROCHEMICAL PREPARATION OF GAMMA-HYDROXYCARBOXYLIC ESTERS AND GAMMA-LACTONES | HBZ, HBG1, EBP | SMN1; SMN2 3776/4885THRB 251/4885ALOX15 463/4885 |
| US-20140100376-A1 | PROCESS FOR THE ELECTROCHEMICAL PREPARATION OF GAMMA-HYDROXYCARBOXYLIC ESTERS AND GAMMA-LACTONES | HBZ, HBG1, EBP | SMN1; SMN2 3776/4885THRB 251/4885ALOX15 463/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.